SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-289408
Filing Date
2019-11-12
Accepted
2019-11-12 09:01:40
Documents
18
Period of Report
2019-11-11
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d657775d8k.htm   iXBRL 8-K 28843
2 EX-99.1 d657775dex991.htm EX-99.1 23029
3 EX-99.2 d657775dex992.htm EX-99.2 49671
7 GRAPHIC g657775g1112072636279.jpg GRAPHIC 5171
8 GRAPHIC g657775g1112072636420.jpg GRAPHIC 2971
9 GRAPHIC g657775g1112072810488.jpg GRAPHIC 5171
10 GRAPHIC g657775g1112072810582.jpg GRAPHIC 2971
  Complete submission text file 0001193125-19-289408.txt   264329

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA myok-20191111.xsd EX-101.SCH 3074
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE myok-20191111_lab.xml EX-101.LAB 17375
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE myok-20191111_pre.xml EX-101.PRE 10956
19 EXTRACTED XBRL INSTANCE DOCUMENT d657775d8k_htm.xml XML 3254
Mailing Address 333 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 333 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 650-741-0900
MyoKardia Inc (Filer) CIK: 0001552451 (see all company filings)

IRS No.: 455500552 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37609 | Film No.: 191206475
SIC: 2834 Pharmaceutical Preparations